Health
Doctors point out that fear of menopausal hormone therapy outweighs real risk
Label changes in the United States reignite the debate over treatment, while experts point out that fear generated by an old study still keeps Brazilian women away from symptom relief.
You have used your 3 free reads for today
The full text of this story becomes available after the daily renewal. Sports and entertainment stay open. The paid subscription is not open yet.
Your free reads renew on 11/15/2026 at 00:00 (Brasília time).
The essentials of this story
- What happened
- Experts argue that fear regarding menopausal hormone therapy is disproportionate to the real risks.
- Who is affected
- Perimenopausal and postmenopausal women, doctors, and patients seeking treatment for symptoms such as hot flashes.
- What changes
- The removal of severe label warnings in the US and the reassessment of studies seek to provide more safety for patients and professionals when prescribing the treatment.
Create a free account to keep reading: 3 full stories a day.
The paid subscription is not on sale yet. Free sign-up already works. Planned monthly price: R$ 9.90 (in US dollars and euros, a direct conversion at the official rate on the day you subscribe).
Sources
- Menopausa: por que médicos dizem que o medo da terapia hormonal é maior que o risco real — BBC News Brasil
- Menopausa: por que médicos dizem que o medo da terapia hormonal é maior que o risco real — Folha de S.Paulo — em cima da hora
- Menopausa: por que médicos dizem que o medo da terapia hormonal é maior que o risco real — UOL — notícias